Mojo Max Fusion XXX, 500 mg, one capsule per blister card
Recalled by Mohamed Hagar
Drug recall
Mohamed Hagar
Class I — most serious
There is a reasonable chance that using this product could cause serious health problems or death.
Mohamed Hagar has recalled Mojo Max Fusion XXX, 500 mg, one capsule per blister card, according to data published by the U.S. Food and Drug Administration (FDA). The recall was reported on March 11, 2026 and was initiated on October 8, 2025. It is classified as a Class I recall, which means there is a reasonable chance that using this product could cause serious health problems or death.
Below is a plain-English summary of what was recalled, why it was recalled, how to tell whether you have the affected product, and what steps you can take. For the complete and most current details, you can view the FDA record linked further down this page.
What was recalled?
This recall covers Mojo Max Fusion XXX, 500 mg, one capsule per blister card, with approximately 125 boxes affected. The company behind the recall is Mohamed Hagar, based in Brooklyn Ctr, MN. The FDA describes the product as: “Mojo Max Fusion XXX, 500 mg, one capsule per blister card, 20 count box, Distributed by: Max Nutrition Inc. UPC 6 78945 36675 0”
Why was Mojo Max Fusion XXX, 500 mg, one capsule per blister card recalled?
According to the FDA, the stated reason for the recall is: “Marketed Without an Approved NDA/ANDA-FDA analysis revealed undeclared sildenafil (13.1 mg/capsule) and tadalafil (13.8 mg/capsule).” In plain terms, this recall relates to an undeclared ingredient or allergen.
An undeclared ingredient means a food contains something — often a major allergen such as milk, eggs, soy, wheat, peanuts, or tree nuts — that is not listed on the label. For most people this is not dangerous, but for someone with a food allergy or sensitivity it can trigger a serious reaction. Accurate labeling is required so that people can avoid ingredients they need to stay away from.
What should you do?
If you think you may have bought Mojo Max Fusion XXX, 500 mg, one capsule per blister card, compare it against the product description and identifying codes (ALL LOTS, exp 12/31/2027) before using it. This recall is currently listed as ongoing.
The general guidance for a matching product is to stop using it and follow the instructions in the official FDA recall notice, which may include a repair, replacement, refund, or safe disposal. When in doubt, contact Mohamed Hagar or your local health authority.
About this recall
This recall was distributed in MN. RecallRadar summarizes recall information from public FDA data to make it easier to understand. We are an independent service and are not affiliated with the FDA or any government agency, so please always refer to the official source for the authoritative record — and note the “last synced” date shown on this page, since recall details can change over time.
Full recall details
- Status
- Ongoing
- Date reported
- March 11, 2026
- Recall started
- October 8, 2025
- Distributed in
- MN
What you can do
Check whether any product you have matches the description and codes above. If it does, stop using it and follow the instructions in the official recall notice. When in doubt, contact the company or your local health authority.
Quick answers
Why was Mojo Max Fusion XXX, 500 mg, one capsule per blister card recalled?+
According to the FDA: Marketed Without an Approved NDA/ANDA-FDA analysis revealed undeclared sildenafil (13.1 mg/capsul…
How serious is this recall?+
Class I — most serious. There is a reasonable chance that using this product could cause serious health problems or death.
What should I do if I have Mojo Max Fusion XXX, 500 mg, one capsule per blister card?+
Compare your product against the description and identifying codes on this page. If it matches, stop using it and follow the instructions in the official recall notice — this usually means returning it for a refund or discarding it. When in doubt, contact the company or your local health authority.
Opens the U.S. Food and Drug Administration (FDA) data for this recall.
Recall number: D-0396-2026. Information last synced from the FDA on July 6, 2026.